Patient Care

SURVIVORSHIP Embracing the ‘new normal’


 

Since 1971, when President Richard M. Nixon announced the “war on cancer” with the signing of the National Cancer Act, we have seen an increase of 300% in the number of survivors, which is now reaching more than 12 million in the United States, according to the Centers for Disease Control. By 2020, that number will likely approach 20 million. Investment in research, early detection, and prevention has contributed to making these numbers a reality, and community-based oncology centers have played a critical role in delivering quality care and improved survival numbers based on the findings of that research. Therefore, it is logical that these same networks of community-based providers that have helped create survivors now help take the next step in addressing the needs of cancer patients on their journey to a life beyond cancer.

*For a PDF of the full article, click in the link to the left of this introduction.

Recommended Reading

Novel Hep C Treatment Excludes Peginterferon Alfa
MDedge Hematology and Oncology
Coronary Disease, Stroke to Drop Below Cancer as Top Killer
MDedge Hematology and Oncology
Stratify Patients for Opioid Misuse and Abuse Risk
MDedge Hematology and Oncology
Practice Changers Expected at San Antonio Breast Cancer Symposium
MDedge Hematology and Oncology
Panel Endorses Surveillance for Low-Risk Prostate Cancer
MDedge Hematology and Oncology
Multiparametric Magnetic Resonance Imaging Identifies Candidates for Prostate Cancer Surveillance
MDedge Hematology and Oncology
Pre-Anthracycline-Based Chemo Cardiac Imaging Questioned
MDedge Hematology and Oncology
We Asked, They Answered: What Is Palliative Care?
MDedge Hematology and Oncology
Community Oncology Podcast: Everolimus in ER-positive breast cancer
MDedge Hematology and Oncology
FDA Issues One REMS for All Transmucosal Fentanyl
MDedge Hematology and Oncology